IL10 and adult-onset Still disease: In particular, M2 macrophages from AOSD and COVID-19 patients treated with PD1 were able to increase the production of the anti-inflammatory cytokine IL-10 and to enhance homeostatic restoration through MIP-1β production from phagocytes.